In the backdrop of the COVID-19 pandemic, while it is of paramount importance to provide early diagnosis and treatment to all infected individuals, it is also critical to promote research and development for larger public health benefit. For development and validation of new diagnostics, therapeutics or vaccines, access to different kinds of clinical samples from infected patients is an essential requirement. Niti Aayog has recently issued guidelines for sharing of biospecimens and data for research related to COVID19. This document in tandem lays down the brief processes and operational mechanisms for establishing COVID19 biorepositories in the country.
[2]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/reports-documents/establishment-network-biorepositories-india
[2] http://www.indiaenvironmentportal.org.in/files/file/Establishment_of_a_network_of_COVID19_Biorepositories_in_India.pdf
[3] http://admin.indiaenvironmentportal.org.in/category/publisher/indian-council-medical-research-icmr
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/coronavirus
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/indian-council-medical-research-icmr
